Splenic Infarction and Myocardial Infarction in A Patient with COVID-19 on Anticoagulant Therapy with Normal D-Dimer Levels
https://doi.org/10.20514/2226-6704-2023-13-6-455-459
Abstract
Many studies have shown that COVID-19 can progress with coagulopathy and multisystem thrombotic pathologies. This article presents the case of a patient who, 9 days after laboratory-confirmed coronavirus pneumonia against the background of anticoagulant therapy, was diagnosed with splenic infarction in combination with acute myocardial infarction during subsequent hospitalization. Prevention of thrombosis with prophylactic doses of low molecular weight heparin in hospitalized patients with COVID-19 may not be sufficient to prevent the development of coagulopathy. Abdominal visceral thromboembolism should be suspected in a COVID-19 positive patient with abdominal pain despite anticoagulant therapy and normal D-dimer levels.
About the Authors
M. I. Grusha
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Simferopol
Competing Interests:
The authors declare no conflict of interests
Y. V. Khametova
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Yunna V. Khametova
Simferopol
Competing Interests:
The authors declare no conflict of interests
A. V. Fedorets
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Simferopol
Competing Interests:
The authors declare no conflict of interests
V. E. Suprunov
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Simferopol
Competing Interests:
The authors declare no conflict of interests
A. S. Minalieva
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Simferopol
Competing Interests:
The authors declare no conflict of interests
G. K. Stakheev
V.I. Vernadsky Crimean Federal University, Institute “Medical Academy named after S.I. Georgievsky”, department of Infectious Diseases
Russian Federation
Competing Interests:
Russian Federation
Simferopol
Competing Interests:
The authors declare no conflict of interests
References
1. de Roquetaillade C., Chousterman B.G., Tomasoni D., et al. Unusual arterial thrombotic events in Covid-19 patients. International Journal of Cardiology. 2021; 323: 281-284. doi: 10.1016/j.ijcard.2020.08.103
2. Santos Leite Pessoa M., Franco Costa Lima C., Farias Pimentel A.C., et al. Multisystemic Infarctions in COVID-19: Focus on the Spleen. European journal of case reports in internal medicine. 2020;7(7):001747. doi: 10.12890/2020_001747
3. Ramanathan M., Chueng T., Fernandez E., et al. Concomitant renal and splenic infarction as a complication of COVID-19: a case report and literature review. Le infezioni in Medicina. 2020; 28(4): 611-615.
4. Karki S., Rawal S.B., Malla S., et al. A case report on spontaneous hemoperitoneum in COVID-19 patient. International Journal of Surgery Case Reports. 2020; 75: 211-213. doi:10.1016/j.ijscr.2020.09.078
5. Castro G.R.A., Collaço I.A., Dal Bosco C.L.B., et al. Splenic infarction as a complication of covid-19 in a patient without respiratory symptoms: A case report and literature review. IDCases. 2021; 24: e01062. doi: 10.1016/j.idcr.2021.e01062
6. Porfidia A., Pola R. Venous thromboembolism in COVID-19 patients. Journal of thrombosis and haemostasis. 2020; 18(6): 1516-1517. doi: 10.1111/jth.14842
7. Voicu S., Bonnin P., Stépanian A., et al. High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients. Journal of the American College of Cardiology. 2020; 76(4): 480-482. doi: 10.1016/j.jacc.2020.05.053
8. Nepogodiev D., Bhangu A., Glasbey J.C., et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020; 396(10243): 27-38. doi: 10.1016/S0140-6736(20)31182-X
9. Ranucci M., Ballotta A., Di Dedda U., et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. Journal of thrombosis and haemostasis. 2020; 18(7): 1747-1751. doi:10.1111/jth.14854
Review
For citations:
Grusha M.I., Khametova Y.V., Fedorets A.V., Suprunov V.E., Minalieva A.S., Stakheev G.K. Splenic Infarction and Myocardial Infarction in A Patient with COVID-19 on Anticoagulant Therapy with Normal D-Dimer Levels. The Russian Archives of Internal Medicine. 2023;13(6):455-458. https://doi.org/10.20514/2226-6704-2023-13-6-455-459
Views:
408
Email this article 